Ibex Unveils Advancements in AI Breast Cancer Diagnostics Platform
Ibex has introduced advancements to its AI-powered platform, enhancing breast cancer diagnostics, improving algorithm accuracy, and more.
Category: Breast
Breast
Latest
Breast
Latest
Breast Cancer Test May Make Bad Chemo Recommendations for Black Patients
The commonly ordered biomarker test is used to guide doctor’s recommendations for patients with estrogen receptor-positive breast cancer.
Breast
Latest
Biocartis Expands APIS Assay Technologies Collab to Commercialize Mutations Kit
Biocartis and APIS Assay Technologies are expanding their collaboration to include the commercialization of the APIS ESR1 Mutations Kit.
DCIS Risk Assessment Test Gets CMS Advanced Diagnostic Laboratory Test Status Approval
The Centers for Medicare & Medicaid Services approved Advanced Diagnostic Laboratory Test status for PreludeDx’s DCISionRT test.
Read More
Medicare Extends Coverage of Natera’s Signatera MRD Test to Breast Cancer
Natera’s Signatera MRD test has met coverage requirements for adjuvant and recurrence monitoring in patients with breast cancer.
Read More
PreciseDx AI-Enabled Breast Diagnostic Gets Approval from NY State
PreciseDx announced that the NYSDOH approved the PDxBr, an LDT designed to enrich breast cancer grading and improve risk categorization.
Read More
AstraZeneca, Ibex Collaborate on Novel AI-Powered HER2 Scoring Product
The companies are collaborating on a product to aid pathologists with an accurate assessment of HER2 IHC scoring in breast cancer patients.Â
Read More
FDA Approves Guardant Health’s CDx Liquid Biopsy for Breast Cancer Patients
The FDA approved the Guardant360 CDx liquid biopsy test as a companion diagnostic for metastatic breast cancer patients with ESR1 mutations.
Read More
Scientists Find New Marker that Predicts Early Breast Cancer Recurrence
Scientists found a marker to identify patients with estrogen receptor-positive breast cancer who may benefit from new immunotherapies.
Read More
PreciseDx AI Platform Predicts Early-Stage Breast Cancer Recurrence
PreciseDx detailed its digital AI platform, which designed to enrich breast cancer grading and improve risk categorization.
Read More
Immune System B-cells Can Help Predict HER2-Positive Breast Cancer Treatment Response
Measuring activation of immune-system B cells may be an ideal method in predicting whether HER2-positive breast cancer responds to treatment.
Read More
Genetic Profiling May Identify Breast Cancer Patients Who Can Omit Radiation Therapy
Breast cancer patients who undergo breast-conserving surgery are recommended to do adjuvant radiation therapy to reduce local recurrence risk.
Read More
RNA-Based Liquid Biopsy Platform Detects Early-Stage Breast Cancer
Researchers released data demonstrating that an RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages.
Read More
Breast Cancer Index Test Predicts Treatment Benefit
Hologic, Inc. has released new study data showing that the Breast Cancer Index test identified which patients benefited from therapy.
Read More
MicroRNAs Can Help Predict Disease Recurrence in Breast Cancer Patients
Researchers have determined that microRNAs can help predict which patients with breast cancer are likely to face a recurrence of the disease.
Read More
Newly Developed Gene Classifier Identifies Risk of Breast Pre-Cancer Progression
A team of researchers made a major advance toward distinguishing if early pre-cancers in the breast will progress into invasive cancers.
Read More
Researchers Find Changes in Blood Proteins Years Before Breast Cancer Diagnosis
Researchers found changes in the levels of particular proteins in people’s blood up to two years prior to a breast cancer diagnosis.
Read More
Breast Cancer Spread Uncovered by New Molecular Microscopy
New technology can trace which populations of breast cancer cells are responsible for the spread of the disease.
Read More